Coronavirus disease–2019 and the intestinal tract: An overview

Table 1 Manuscripts describing patients with severe acute respiratory syndrome coronavirus-2 ribonucleic acid detection in rectal swabs or fecal samples

COVID-19 respiratory manifestations	COVID-19 gastrointestinal clinical manifestations	Percentage of patients with gastrointestinal clinical manifestations	Rectal swabs or fecal samples positive for SARS-CoV-2	Ref.
Yes	Yes	65.38%	53.42%	[16]
Yes	Yes	60%	50%	[122]
Yes	Yes	80%	90%	[123]
Yes	Yes	11%	22%	[124]
Yes	Yes	33%	80%	[125]
Yes	Yes	No data	39%	[126]
Yes (89 only respiratory/69 respiratory and gastrointestinal)	Yes (48 only gastrointestinal/69 respiratory and gastrointestinal)	56%	54% of a cohort of 22 individuals	[127]
Yes	Yes	No data	29%	[128]
Yes	Yes	31%	55%	[24]
Yes	Yes	No data	83%	[129]
Yes	Yes	No data	25%	[130]

COVID-19: Coronavirus disease–2019; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2.